Mechanisms accounting for granulomatous responses in hypersensitivity pneumonitis

Sarcoidosis Vasculitis and Diffuse Lung Disease

Volumn 14, Issue 2, 1997, Pages 131-138

  Suga, Moritaka ^a   Yamasaki, Hisato ^a   Nakagawa, Kazuko ^a   Kohrogi, Hirotsugu ^a   Ando, Masayuki ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

CD4+ T cell; CD8+ T cell; Chemokines; Cytokines; Extrinsic allergic alveolitis; Granuloma formation; Hypersensitivity pneumonitis; Monokines; RANTES; T cell subsets

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 2; MACROPHAGE ACTIVATING FACTOR; MACROPHAGE CHEMOTACTIC FACTOR; MACROPHAGE MIGRATION INHIBITION FACTOR; TUMOR NECROSIS FACTOR;

ALLERGIC PNEUMONITIS; CELL SUBPOPULATION; DELAYED HYPERSENSITIVITY; EPITHELIOID CELL; GIANT CELL; GRANULOMATOSIS; HELPER CELL; HUMAN; LYMPHOCYTE MIGRATION; MACROPHAGE; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ALLERGENS; ALVEOLITIS, EXTRINSIC ALLERGIC; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINES; CYTOKINES; GRANULOMA; HUMANS; MACROPHAGES, ALVEOLAR; MAST CELLS; T-LYMPHOCYTES;

EID: 0030779912     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Fink JN: Hypersensitivity pneumonitis. J Allergy Clin Immunol 1984; 74: 1-9.
2. Richerson HB, Bernstein IL, Fink JN et al: Guidelines for the clinical evaluation of hypersensitivity pneumonitis: report of the subcommittee on hypersensitivity pneumonitis. J Allergy Clin Immunol 1989; 84: 839-844.
3. Fink JN: Epidemiologic aspects of hypersensitivity pneumonitis. In Schlumberger HD (ed): Monography in Allergy. S Karger. Basel, 1987; 59-69.
4. Lopez M, Salvaggio JE: Epidemiology of hypersensitivity pneumonitis. In Schlumberger HD (ed): Monography in Allergy. S Karger. Basel. 1937; 70-86.
5. Ando M, Arima K, Yoneda R, Tamura M: Japanese summer-type hypersensitivity pneumonitis: geographic distribution, home environment, and clinical characteristics of 621 cases. Am Rev Respir Dis 1991; 144: 765-769.
6. Kaltreider HB:Hypersensitivity pneumonitis. West J Med 1993; 159: 570-578.
7. Reynolds HY: Concepts of pathogenesis and lung reactivity in hypersensitivity pneumonitis. Ann NY Acad Sci 1986; 465: 287-303.
8. Costabel U: The alveolitis of hypersensitivity pneumonitis. Eur Respir J 1988; 1: 5-9.
9. Salvaggio JE: Recent advances in the pathogenesis of allergic alveolitis. Clin Exp Allergy 1990; 20: 137-144.
10. Boros DL: Experimental granulomatous disease. In Fanburg BL (ed): Sarcoidosis and other granulomatous diseases of the lung. Marcel Dekker, New York, 1991; 403-449.
11. Ando M, Dannenberg AM Jr, Shima K: Macrophage accumulation, division, maturation and digestive and microbicidal capacities in tuberculous lesions. II. Rate at which mononuclear cells enter and divide in primary BCG lesions and those of reinfection. J Immunol 1972; 109: 8-19.
12. Cantor H, Boyse EA: Functional subclasses of T lymphocytes bearing different Ly antigen. J Exp Med 1975; 141: 1376-1399.
13. Snapper CM, Paul WE:Interferon-γ and Bcell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987; 236: 44-47.
14. Snapper CM, Finkelman FD, Paul WE: Differential regulation of IgG1 and Ig isotope production. J Exp Med 1988; 167: 183-196.
15. + T cells. J Exp Med 1991; 174: 875-880.
16. Ju ST: Distinct pathways of CD4 and CD8 cells induce rapid target DNA fragmentation. J Immunol 1991; 146: 812-818.
17. Dannenberg AM Jr, Ando M, Shima K: Macrophage accumulation, division, maturation and digestive and microbicidal capacities in tuberculous lesions. III. The turnover of macrophages and its relation and antimicrobial immunity in primary BCG lesions and those of reinfection. J Immunol 1972; 109: 1109-1121.
18. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348-2357.
19. Miller SD, Karpus WJ: The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol Today 1994; 15: 356-361.
20. Mosmann TR, Sad S:The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17: 138-146.
21. Nedwin GE, Svedersky LP, Bringman TS, Palladino MA, Goeddel DV: Effect of IL-2, INFγ, and mitogens on the production of TNFα and ß. J Immunol 1985; 135: 2492-2497.
22. Collart MA, Belin D, Vassali J, DeKossodo S, Vassali D: IFNγ enhances macrophage transcription of the IFN, IL-1 and urokinase gene, which are controlled by short-lived respondcrs. J Exp Med 1986; 164: 2113-2124.
23. 2 and glucoconicoids on the production of TNFα. J Leukocyte Biol 1990; 43: 473-481.
24. Philip R, Epstein LB: Tumor necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself. Interferon gamma and interleukin-1. Nature 1986; 323: 86-89.
25. Delannoy I, Lekeux P, Miossec P: Cytokine and anti-cytokine strategies in inflammatory reaction modulation. Vet Res 1993; 24: 449-467.
26. Doherty TM: T-cell regulation of macrophage function. Curr Opin Immunol 1995; 7: 400-404.
27. Kunkel SL, Chensue SW, Strieter RM, Lynch JP, Remick DG: Cellular and molecular aspects of granulomatous inflammation. Am J Respir Cell Mol Biol 1989; 1: 439-447.
28. Fiorentino DF, Bond MW, Mosmann TR: Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081-2095.
29. Martinez OM, Gibbons RS, Garovoy MR, Aronson FR: IL-4 inhibits IL-2 receptor expression and IL-2 dependent proliferation of human T cells. J Immunol 1990; 144: 2211-2215.
30. Ho JL, He SH, Rios MJ, Wick EA: Interleukin-4 inhibits human macrophage activation by tumor necrosis factor, granulocyte-monocyte colony-stimulating factor, and interleukin-3 for antileishmanial activity and oxidative burst capacity. J Infect Dis 1992; 165: 344-351.
31. Reynolds HY, Fulmer JD, Kazmierowski JA, Roberts WC, Frank MM, Crystal RG: Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest 1977; 59: 165-175.
32. Semenzato G, Agostini C, Zambello R et al: Lung T cells in hypersensitivily pneumonitis: phenotypic and functional analysis. J Immunol 1986; 137: 1164-1172.
33. Leatherman JW, Michael AF, Schwartz BA, Hoidal JR: Lung T cells in hypersensitivity pneumonitis. Ann Intern Med 1984; 100: 390-392.
34. Cormier Y, Belanger J, Laviolette M: Prognostic significance of bronchoalveolar lymphocytosis in farmer's lung. Am Rev Respir Dis 1987; 135: 692-695.
35. Brummund W, Kurup VP, Resnick A, Milson TJ Jr, Fink JN: Immunologic response to Faenia rectivirgula (Micropolyspora faeni) in a dairy farm family. J Allergy Clin Immunol 1988; 82: 190-195.
36. Tomichi N, Yagawa K, Moori T, Tamura M: Immunohistochemical study of T cell subsets in lung tissue and in BALF of patients with farmer's lung disease. Allergy 1989; 38: 508-512.
37. Ando M, Konish K, Yoneda R, Tamura M: Difference in the phenotypes of bronchoalveolar lavase lymphocytes in patients with summer-type hypersensitivity pneumonitis, farmer's lung, ventilation pneumonitis, and bird fancier's lung: report of a nationwide epidemiologic study in Japan. J Allergy Clin Immunol 1991; 87: 1002-1009.
38. Keller RH, Swartz S, Schlueter DP, Bar-Sela S, Fink JN: Immunoregulation in hypersensitivity pneumonitis: phenotypic and functional studies of bronchoalveolar lavage lymphocytes. Am Rev Respir Dis 1984; 130: 766-771.
39. Costabel U, Bross KJ, Ruhle KH, Löhr GW, Matthys H: Ia-like antigens on T-cells and their subpopulations in pulmonary sarcoidosis and in hypersensitivity pneumonitis: analysis of bronchoalveolar and blood lymphocytes. Am Rev Respir Dis 1985; 131: 337-342.
40. Trentin L, Marcer G, Chilosi M et al: Longitudinal study of alveolitis in hypersensitivity pneumonitis patients: an immunologic evaluation. J Allergy Clin Immunol 1988; 82: 577-585.
41. Tomichi N, Shikanai T, Sakamoto S, Takayama K, Tamura M, Ando M: Comparative histopathological analysis of lung biopsy specimens in patients with farmer's lung disease and summer-type hypersensitivity pneumonitis. Am J Respir Crit Care Med 1995; 151: A606.
42. Trentin L, Migone N, Zambello et al: Mechanisms accounting for lymphocytic alveolitis in hypersensitivity pneumonitis. J Immunol 1990: 145; 2147-2154.
43. Moore VL, Pedersen GM, Hauser WC, Fink JN: A study of lung lavage materials in patients with hypersensitivity pneumonitis: in vitro response to mitogen and antigen in pigeon breeders' disease. J Allergy Clin Immunol 1980; 65: 365-370.
44. Saltini C, Kirby M, Trapnell BC, Costal RG: Biased accumulation of T lymphocytes with "memory"-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung. J Exp Med 1990; 171: 1123-1140.
45. Schuyler M, Gott K, Edwards B, Nikula KJ: Experimental hypersensitivity pneumonitis: effect of CD4 cell depletion. Am J Respir Crit Care Med 1994; 149: 1286-1294.
46. + cell depletion. Am J Respir Crit Care Med 1995; 151: 1834-1842.
47. Denis M, Cormier Y, Laviolette M, Ghadirian E: T cells in hypersensitivity pneumonitis: effects of in vivo depletion of T cells in a mouse model. Am J Respir Cell Mol Biol 1992; 6: 183.
48. Ito K, Yamasaki H, Onoue K, Ando M: Experimental hypersensitivity pneumonitis in mice induced by Trichosporon cutaneum: histologic and immunologic features and effect of in vivo depletion of T cell subsets. Exp Lung Res 1993; 19: 631-652.
49. + lymphocytes in a LEW rat model of hypersensitivity pneumonitis. J Allergy Clin Immunol 1995; 96: 113-121.
50. Semenzato G, Trentin L, Zambello R, Agostini C, Cipriani A, Marcer G: Different types of cytotoxic lymphocytes recovered from the lungs of patients with hypersensitivity pneumonitis. Am Rev Respir Dis 1988; 137: 70-74.
51. Richerson HB, Coon JD, Lubaroff D: Experimental hypersensitivity pneumonitis in the rat: histopathology and T-cell subset compartmentalization. Am J Respir Cell Mol Biol 1991; 5: 451-463.
52. Ely JM, Greiner DL, Lubaroff DM, Fitch FW: Characterization of monoclonal antibodies that define rat T cell alloantigens. J Immunol 1983; 130: 2798-2803.
53. Lubaroff DM, Rasmussen GT, Hunt HD: The RT6 T cell antigen: its role in the identification of functional subsets and in T cell activation. Transplant Proc 1989; 21: 3251-3254.
54. + T cells does not impair the pulmonary immune response to intratracheal antigen. Am J Respir Cell Mol Biol 1993; 9: 90-98.
55. Salgame P, Abrams JS, Clayberger C et al: Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991; 254: 279-282.
56. Keller RH, Swartz S, Schlueter DP, Bar-Sela S, Fink JN: Immunoregulation in hypersensitivity pneumonitis: phenotypic and functional studies of bronchoalveolar lavage lymphocytes. Am Rev Respir Dis 1984; 130: 766-771.
57. McCombs CC, Michalski JP, Westerfield BT, Light RW: Human alveolar macrophages suppress the proliferative responses of peripheral blood lymphocytes. Chest 1982; 82: 266-271.
58. Swisher SG, Kiertscher SM, Golub SH, Holmes EC, Roth MD: Pulmonary macrophages suppress the proliferation and cytotoxicity of tumor-infiltrating lymphocytes. Am J Respir Cell Mol Biol 1993; 8: 486-492.
59. Steele MG, Herscowitz HB: Suppression of murine IgM, IgG, IgA and IgE antibody responses by alveolar macrophages. Immunology 1993; 80: 62-67.
60. Yamasaki H, Kinoshita T, Ohmura T et al: Lowered responsiveness of bronchoalveolar lavage T lymphocytes in hypersensitivity pneumonitis. Am J Respir Cell Mol Biol 1991; 4: 417-425.
61. Kopp WC, Suelzer MT, Richerson HB: Alveolar macrophage immunosuppression is maintained in rabbit models of hypersensitivity pneumonitis. J Allergy Clin Immunol 1988; 82: 204-212.
62. Cormier Y, Dakhama A, Israel-Assayag E: Altered immunosuppressive function of alveolar macrophages in hypersensitivity pneumonitis. Am J Respir Crit Care Med 1995; 151: A605.
63. Haslam PL, Dewar A, Butchers P, Primett ZS, Newman-Taylor A, Turner-Warwick M: Mast cells, atypical lymphocytes, and neutrophils in bronchoalveolar lavage in extrinsic allergic alveolitis. Am Rev Respir Dis 1987; 135: 35-47.
64. Takizawa H, Ohta K, Hirai K et al: Mast cells are important in the development of hypersensitivity pneumonitis. A study with mast-cell-deficient mice. J Immunol 1989; 143: 1982-1988.
65. Ishida T, Matsui Y, Matsumura Y, Fujimori N, Furutani M: Bronchoalveolar mast cells in summer-type hypersensitivity pneumonitis: increase in numbers and ultrastructural evidence of degranulation. Intern Med 1995; 34: 357-363.
66. Denis M: Proinflammatory cytokines in hypersensitivity pneumonitis. Am J Respir Crit Care Med 1995; 151: 164-169.
67. Yoshimura T, Yuhki N, Moore SK, Appella E, Lerman MI, Leonard EJ: Human monocyte chemoattractant protein-1 (MCP-1). Full length cDNA cloning expression in mitogen-stimulated blood mononuclear phagocytes. FEBS Lett 1989; 244: 487-493.
68. Matsushima K, Oppenheim JJ: Interleukin 8 and MCAF: Novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1989; 1: 2-13.
69. + T cells in response to MIP-1α and MIP-1ß. Science 1993; 260: 355-358.
70. Schall TJ, Bacon K, Toy KJ, Goeddel DV: Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990; 347: 669-671.
71. Denis M, Cormier Y, Fournier M, Tardif J, Laviolette M: Tumor necrosis factor plays an essential role in determinins hypersensitivity pneumonitis in a mouse model. Am J Respir Cell Mol Biol 1991; 5: 477-433.
72. Fahey TJ III, Tracey KJ, Tekamp-Olson P et al: Macrophage inflammation protein-1 modulates macrophage function. J Immunol 148: 2764-2769.
73. Doherty TM: T-cell regulation of macrophage function. Curr Opin Immunol 1995; 7: 400-404.